Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Butzkueven

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Neurology|April 12, 2007
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, AustraliaI A F van der Mei, A-L Ponsonby, T Dwyer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Monitoring cognitive change in multiple sclerosis using a computerized cognitive batteryL De Meijer, D Merlo, O Skibina, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 23, 2006
Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapsesC Chapman, N Tubridy, M J Cook, et al.
AJNR. American Journal of Neuroradiology|February 5, 2022
Lesion Volume in Relapsing Multiple Sclerosis is Associated with Perivascular Space Enlargement at the Level of the Basal GangliaS C Kolbe, L M Garcia, N Yu, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 23, 2012
Diffusion tensor imaging of acute inflammatory lesion evolution in multiple sclerosisY Liu, P J Mitchell, T J Kilpatrick, et al.
Tissue Antigens|April 28, 2009
HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosisJ Stankovich, H Butzkueven, M Marriott, et al.
Neurology|September 30, 2009
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophyA van der Walt, J Stankovich, M Bahlo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognitionAnneke Van der Walt, J Stankovich, M Bahlo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosisH Butzkueven, J Chapman, E Cristiano, et al.
Neurology|October 26, 2011
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosisM S Stein, Y Liu, O M Gray, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Neurology|April 12, 2007
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, AustraliaI A F van der Mei, A-L Ponsonby, T Dwyer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Monitoring cognitive change in multiple sclerosis using a computerized cognitive batteryL De Meijer, D Merlo, O Skibina, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 23, 2006
Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapsesC Chapman, N Tubridy, M J Cook, et al.
AJNR. American Journal of Neuroradiology|February 5, 2022
Lesion Volume in Relapsing Multiple Sclerosis is Associated with Perivascular Space Enlargement at the Level of the Basal GangliaS C Kolbe, L M Garcia, N Yu, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 23, 2012
Diffusion tensor imaging of acute inflammatory lesion evolution in multiple sclerosisY Liu, P J Mitchell, T J Kilpatrick, et al.
Tissue Antigens|April 28, 2009
HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosisJ Stankovich, H Butzkueven, M Marriott, et al.
Neurology|September 30, 2009
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophyA van der Walt, J Stankovich, M Bahlo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognitionAnneke Van der Walt, J Stankovich, M Bahlo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosisH Butzkueven, J Chapman, E Cristiano, et al.
Neurology|October 26, 2011
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosisM S Stein, Y Liu, O M Gray, et al.
Pageof 5